WillowEdge Robotics Completes Pre-A+ Financing to Advance Clinical Trials for Three Surgical Robots

VCBeat has learned that Shenzhen Lancet Robot Co., Ltd. (“Lancet Robot”), a surgical robotics company, recently announced the completion of its Pre-A+ financing round, raising tens of millions of yuan. The investment was led by Puxin Health Medical Industry Equity Investment Fund. The proceeds will be primarily used to advance the clinical studies required for Chinese regulatory registration of the company’s three surgical robot models and to continuously expand its product portfolio. This investment in Lancet Robot is regarded as a key component of Puxin Health Medical Industry Equity Investment Fund’s strategic layout in the surgical robotics sector.

It is worth noting that Shenzhen Lancet Robot Co., Ltd. has successfully completed three rounds of financing in the second half of this year. The ability to rapidly secure multiple funding rounds within a short period fully demonstrates the company’s core competitiveness and investment value. Furthermore, bolstered by this capital infusion, clinical trials for multiple products under Shenzhen Lancet Robot have been accelerated.

It is understood that the hip replacement surgical robot, knee replacement surgical robot, and dental implant surgical robot developed by Lancet Robot have all entered the clinical stage for registration in China and achieved excellent clinical performance.

Furthermore, Lancet Robot has established a comprehensive presence in intelligent surgical solution platform software. Notably, its digital orthopedic surgery software has obtained Class II medical device registration and is being promoted and used in multiple medical institutions. Intelligent software products for orthopedics and dentistry, featuring automated surgical planning capabilities, are also poised to initiate clinical trials and apply for Class III medical device registration.

Looking ahead, Shenzhen Lancet Robot Co., Ltd. will remain steadfast in its focus on enhancing the precision, digitalization, and intelligence of surgical procedures in orthopedics and dentistry, continuously empowering smart healthcare to create new value for the industry.